Hypertension Secondary to Pheochromocytoma

  • William M. Manger
  • Ray W. GiffordJr.
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 16)


The clinical expressions of pheochromocytoma are often dramatic and explosive, and are so variable that it has rightly earned the title of the ‘great mimic’ [1]. One cannot determine histologically whether a pheochromocytoma is benign or malignant. Although only 10% of these neoplasms are pathologically malignant, as evidenced by metastasis or invasion of adjacent tissue, lethal complications from the effects of excessive circulating catecholamines (epinephrine and norepinephrine) almost invariably result if the disease is not appropriately treated. All patients with manifestations even remotely suggestive of pheochromocytoma must be screened for this disease.


Medullary Thyroid Carcinoma Multiple Endocrine Neoplasia Type Multiple Endocrine Neoplasia Urinary Catecholamine Sustained Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Decourcy JL, Decourcy CB: Pheochromocytomas and the General Practitioner. Cincinnati: Barclay Newman, 1952.Google Scholar
  2. 2.
    Manger WM, Gifford RW Jr: Pheochromocytoma. New York: Springer-Verlag, 1977.CrossRefGoogle Scholar
  3. 3.
    Winkler H, Smith AD: Pheochromocytomas and other catecholamine-producing tumors. In: Catecholamines, p. 900. Blaschko H, Muscholl E, eds. New York: Springer-Verlag, 1972.Google Scholar
  4. 4.
    Hermann H, Mornex R: Human Tumours Secreting Catecholamines: Clinical and Physiopathological Study. Oxford: Pergamon, 1964.Google Scholar
  5. 5.
    Steiner Al, Goodman AD, Powers SR: Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing’s disease: multiple endocrine neoplasia type 2. Medicine 37: 371, 1968.CrossRefGoogle Scholar
  6. 6.
    Thomas JE, Rooke ED, Kvale WF. The neurologist’s experience with pheochromocytoma. A review of 100 cases. J Am Med Assoc. 197: 754, 1966.CrossRefGoogle Scholar
  7. 7.
    Remine WH, Chong GC, van Heerden JA, Sheps SG, Harrison EG Jr: Current management of pheochromocytoma, Ann Surg 179: 740, 1974.PubMedCrossRefGoogle Scholar
  8. 8.
    Minno AM, Bennett WA, Kvale WF: Pheochromocytoma; a study of 15 cases diagnosed at autopsy. N Engl J Med 251: 959, 1954.PubMedCrossRefGoogle Scholar
  9. 9.
    Aranow H Jr: Pheochromocytoma. In: Monographs in Medicine, p. 179. Bean WE, ed. Series 1. Baltimore: Williams & Wilkins, 1952.Google Scholar
  10. 10.
    Taubman I, Pearson OH, Anton AH: An asymptomatic catecholamine-secreting pheochromocytoma. Am J Med 57: 953, 1974.PubMedCrossRefGoogle Scholar
  11. 11.
    Sjoerdsma A: Sympathoadrenal system: Pheochromocytoma. In: Cecil Loeb Textbook of Medicine. Beeson PB, McDermott W, eds. 13th edn, p. 1832. Philadelphia: W. B. Saunders, 1971.Google Scholar
  12. 12.
    Engelman K, Zelis R, Waldmann T, Mason DT, Sjoerdsma AM: Mechanism of orthostatic hypertension in pheochromocytoma. Circulation (suppl 6 ) 38: 72, 1968.Google Scholar
  13. 13.
    Keith NM, Wagener HP, Barker NW: Some different types of essential hypertension: their course and prognosis. Am J Med Sci 197: 332, 1939.CrossRefGoogle Scholar
  14. 14.
    Hume DM: Pheochromocytoma in the adult and in the child. Am J Surg 99: 458, 1960.PubMedCrossRefGoogle Scholar
  15. 15.
    Leestma JE, Price EB Jr. Paraganglioma of the urinary bladder. Cancer 28: 1063, 1971.PubMedCrossRefGoogle Scholar
  16. 16.
    Khairi MR, Dexter RN, Burzynski NJ, Johnston CC Jr: Mucosal neuroma, pheochromocytoma and medullary thyroid carcinoma: Multiple endocrine neoplasia type 3. Medicine 54: 89, 1975.PubMedGoogle Scholar
  17. 17.
    Carney JA, Go VL, Sizemore GW, Hayles AB: Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple neoplasia, type 2b. N Engl J Med 295: 1287, 1976.PubMedCrossRefGoogle Scholar
  18. 18.
    Carney J A, Sizemore GW, Lovestedt SA. Mucosal ganglioneuromatosis, medullary thyroid carcinoma, and pheochromocytoma: Multiple endocrine neoplasia, Type 2b. Oral Surg 41: 739, 1976.PubMedCrossRefGoogle Scholar
  19. 19.
    Chong GC, Beahrs OH, Sizemore GW, Woolner LH: Medullary carcinoma of the thyroid gland. Cancer 35: 695, 1975.PubMedCrossRefGoogle Scholar
  20. 20.
    Robertson DM, Sizemore GW, Gordon H. Thickened corneal nerves as a manifestation of multiple endocrine neoplasia. Trans Am Acad Ophthalmol Otolaryngol 79: 772, 1975.Google Scholar
  21. 21.
    Brasfield RD, Das Gupta TK: Von Recklinghausen’s disease: a clinicopathological study. Ann Surg 175: 86, 1972.PubMedCrossRefGoogle Scholar
  22. 22.
    DeQuattro V, Chan S: Raised plasma-catecholamines in some patients with primary hypertension. Lancet 1: 806, 1972.PubMedCrossRefGoogle Scholar
  23. 23.
    Stewart BH, Bravo EL, Haaga J, Meaney TF, Tarazi R: Localization of pheochromocytoma by computed tomography. N Engl J Med 299: 460, 1978.PubMedCrossRefGoogle Scholar
  24. 24.
    Wallace JM, Gill DP: Prazosin in the diagnosis and treatment of pheochromocytoma. J Am Med Assoc 240: 2752, 1978.CrossRefGoogle Scholar
  25. 25.
    Rosei EA, Brown J J, Lever AF. Treatment of phaeochromocytoma and of Clonidine withdrawal hypertension with labetalol. Br J Clin Pharmacol 3 (suppl 3): 809, 1976.PubMedGoogle Scholar
  26. 26.
    El-Minawi MF, Paulino E, Cuesta M, Ceballos J: Pheochromocytoma masquerading as pre-eclamptic toxemia. Am J Obstet Gynecol 109: 389, 1971.PubMedGoogle Scholar
  27. 27.
    Allen CT, Imrie D: Hypoglycemia as a complication of removal of a pheochromocytoma. Can Med Assoc J 116: 363, 1977.PubMedGoogle Scholar
  28. 28.
    Wilkins GE, Schmidt N, Doll WA. Hypogycemia following excision of pheochromocytoma. Can Med Assoc J 116:367, 1977.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, The Hague 1982

Authors and Affiliations

  • William M. Manger
  • Ray W. GiffordJr.

There are no affiliations available

Personalised recommendations